Ndumnego O, Crafford J, Beyer W, van Heerden H
BMC Vet Res. 2013; 9:265.
PMID: 24373579
PMC: 3892015.
DOI: 10.1186/1746-6148-9-265.
Chun J, Choi O, Cho M, Hong K, Seong W, Oh H
Osong Public Health Res Perspect. 2013; 3(3):170-6.
PMID: 24159510
PMC: 3738701.
DOI: 10.1016/j.phrp.2012.07.006.
Dumas E, Nguyen M, Cox P, Rodgers H, Peterson J, James J
Vaccine. 2013; 31(14):1856-63.
PMID: 23415781
PMC: 3614092.
DOI: 10.1016/j.vaccine.2013.01.040.
Li Q, Peachman K, Sower L, Leppla S, Shivachandra S, Matyas G
Open Vaccine J. 2011; 2:92-99.
PMID: 20390054
PMC: 2853182.
DOI: 10.2174/1875035400902010092.
Cybulski Jr R, Sanz P, OBrien A
Mol Aspects Med. 2009; 30(6):490-502.
PMID: 19729034
PMC: 2783700.
DOI: 10.1016/j.mam.2009.08.006.
MECHANISM OF ACTION OF THE TOXIN OF BACILLUS ANTHRACIS II. : Alkaline Phosphatasemia Produced by Culture Filtrates of Various Bacilli.
SLEIN M, Logan G
J Bacteriol. 1962; 83(2):359-69.
PMID: 16561930
PMC: 277738.
DOI: 10.1128/jb.83.2.359-369.1962.
Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines.
Phipps A, Premanandan C, Barnewall R, Lairmore M
Microbiol Mol Biol Rev. 2004; 68(4):617-29.
PMID: 15590776
PMC: 539006.
DOI: 10.1128/MMBR.68.4.617-629.2004.
Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
Marcus H, Danieli R, Epstein E, Velan B, Shafferman A, Reuveny S
Infect Immun. 2004; 72(6):3471-7.
PMID: 15155654
PMC: 415724.
DOI: 10.1128/IAI.72.6.3471-3477.2004.
THE BIOLOGIC ACTIVITIES OF BACILLUS ANTHRACIS AND BACILLUS CEREUS CULTURE FILTRATES.
Bonventre P, ECKERT N
Am J Pathol. 1963; 43:201-11.
PMID: 14076029
PMC: 1949758.
Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis.
Wright G, Puziss M, Neely W
J Bacteriol. 1962; 83:515-22.
PMID: 14008433
PMC: 279305.
DOI: 10.1128/jb.83.3.515-522.1962.
Observations on penicillin prophylaxis of experimental inhalation anthrax in the monkey.
GOCHENOUR Jr W, GLEISER C, TIGERTT W
J Hyg (Lond). 1962; 60:29-33.
PMID: 13899371
PMC: 2134473.
DOI: 10.1017/s0022172400039279.
Production of toxin in vitro by Bacillus anthracis and its spearation into two components.
THORNE C, MOLNAR D, STRANGE R
J Bacteriol. 1960; 79:450-5.
PMID: 13838209
PMC: 278706.
DOI: 10.1128/jb.79.3.450-455.1960.
Immunochemically-active cross-linked polystyrene preparations.
KENT L, SLADE J
Biochem J. 1960; 77:12-7.
PMID: 13752555
PMC: 1204891.
DOI: 10.1042/bj0770012.
The basis of immunity to anthrax.
Smith H
Proc R Soc Med. 1958; 51(5):375-7.
PMID: 13567682
PMC: 1889625.
Further purification studies on the protective antigen of Bacillus anthracis produced in vitro.
STRANGE R, THORNE C
J Bacteriol. 1958; 76(2):192-202.
PMID: 13563416
PMC: 290183.
DOI: 10.1128/jb.76.2.192-202.1958.
The chemical basis of the virulence of Bacillus anthracis. VII. Two components of the anthrax toxin: their relationship to known immunising aggressins.
Smith H, Tempest D, Stanley J, HARRIS-SMITH P, GALLOP R
Br J Exp Pathol. 1956; 37(3):263-71.
PMID: 13342351
PMC: 2082151.
Observations on the prophylaxis of experimental pulmonary anthrax in the monkey.
Henderson D, Peacock S, BELTON F
J Hyg (Lond). 1956; 54(1):28-36.
PMID: 13319688
PMC: 2217997.
DOI: 10.1017/s0022172400044272.
A method for assaying anthrax immunising antigen and antibody.
BELTON F, Henderson D
Br J Exp Pathol. 1956; 37(2):156-60.
PMID: 13315890
PMC: 2082562.
The chemical basis of the virulence of Bacillus anthracis. VI. An extracellular immunising aggressin isolated from exudates of infected guinea-pigs.
Smith H, GALLOP R
Br J Exp Pathol. 1956; 37(2):144-55.
PMID: 13315889
PMC: 2082560.
The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. Anthracis in vivo.
Smith H, Keppie J, Stanley J
Br J Exp Pathol. 1955; 36(5):460-72.
PMID: 13269658
PMC: 2083345.
